Error message

The page you requested does not exist. For your convenience, a search was performed using the query Cardiovascular Metabolism.

Page not found

Search results

  1. Sell Your Science- Best Practices for Developing an Effective Non-Confidential Pitch Deck

    & Johnson Innovation, Boston. He focuses primarily on cardiovascular & metabolic; infectious ...

  2. [NYC session] From Chemical to Drug- The Path to a Small Molecule IND

    in the Cardiovascular and Metabolism, Immunology, Neuroscience, and Oncology therapeutic areas. In addition to using ... Cardiovascular and Metabolism therapeutic areas. Mike is also the Janssen R&D preclinical scientific liaison ... to facilitate clinical drug development and approval in cardiovascular, metabolic, immunology, and oncology ...

  3. JLABS and TMCx Brunch

    the future look like in the fight against obesity and metabolic disease? Rising rates of obesity impact our ... on metabolic disease and the varied treatment options in an effort to further the fight against obesity ... and related metabolic diseases. This event will tackle the following questions: What makes mechanisms driving ...

  4. JLABS and TMCx Brunch

    the future look like in the fight against obesity and metabolic disease? Rising rates of obesity impact our ... on metabolic disease and the varied treatment options in an effort to further the fight against obesity ... and related metabolic diseases. This event will tackle the following questions: What makes mechanisms driving ...

  5. From Chemical to Drug- The Path to a Small Molecule IND

    Pharmacology Therapeutic Area Head for the Cardiovascular & Metabolism and Immunology Therapeutic Areas ... for the Cardiovascular & Metabolism Therapeutic Area. ^ Back to Speakers' list ^ Bethany Paxson | Sr. Director, ... Preclinical Development strategies for pharmacokinetics, drug metabolism and toxicology    - Key CMC ...

  6. Meet Ibraheem Badejo, PhD, Senior Director, New Ventures, Medical Devices

    and enhance our portfolio in is bariatrics and treatment for metabolic diseases. Serious complications ... as cardiovascular/specialty and select cardiovascular diseases. Within each of these focus areas, we are working to identify ... to de-risk early stage transformative solutions for the Ethicon and Cardiovascular & Specialty Solutions ...

  7. The Path to a Small Molecule IND

    for a portfolio of discovery and development projects in the Oncology, Cardiovascular and Metabolism therapeutic ... strategies for pharmacokinetics, drug metabolism and toxicology    - Key CMC strategies to balance cost, time ... Development Strategies  - Designing drugable molecules with appropriate kinetics and metabolism- Preclinical ...

  8. The Path to a Small Molecule IND

    for a portfolio of discovery and development projects in the Oncology, Cardiovascular and Metabolism therapeutic ... strategies for pharmacokinetics, drug metabolism and toxicology    - Key CMC strategies to balance cost, time ... Development Strategies  - Designing drugable molecules with appropriate kinetics and metabolism- Preclinical ...

  9. The Path to a Small Molecule IND

    for a portfolio of discovery and development projects in the Oncology, Cardiovascular and Metabolism therapeutic ... strategies for pharmacokinetics, drug metabolism and toxicology    - Key CMC strategies to balance cost, time ... Development Strategies  - Designing drugable molecules with appropriate kinetics and metabolism- Preclinical ...

  10. [San Antonio TX session] Sell Your Science: Best Practices for Developing an Effective Non-Confidential Pitch Deck

    on cardiovascular & metabolic; infectious diseases and Vaccines; and neurobiology. Prior to joining the Johnson ...

Pages

Share